Investors

Osprey Medical is
dedicated to making
angiography safer
for chronic kidney
disease patients.

Osprey Medical designs, develops, and manufactures proprietary devices and monitoring systems that reduce the amount of X-ray dye (contrast) used during commonly performed heart imaging procedures.

Our Mission

To improve outcomes in patients suffering from Chronic Kidney Disease (CKD) by reducing contrast induced Acute Kidney Injury (AKI) and lowering hospital costs.

35%

Revenue growth*

36%

Unit growth*

*Q4 ’18 vs. Q4 ’19

In the News

Supplier Horizon Award

Osprey receives Supplier Horizon Award from Premier Inc

Osprey Medical has been selected as a Supplier Horizon Award recipient by Premier Inc., one of nine suppliers to win the prestigious award, and is the only cardiovascular supplier to receive the award this year.
Read more
DyeVert Logo

GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI)

Osprey Medical (ASX: OSP) today announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia, Middle East, Africa, Central Asia and Turkey. Osprey’s DyeVert contrast minimization devices, complemented by GE Healthcare's range of iodinated x-ray contrast media, offer healthcare professionals a technology platform to address the rising problem of Acute Kidney Injury (AKI) following interventional coronary angiograms in patients with Chronic Kidney Disease (CKD).
Read more

All Osprey Medical News

Osprey Medical’s product specific labeling indications may vary by geography.

© 2021 Osprey Medical Inc. All rights reserved.
Osprey Medical, DyeVert, DyeMINISH, and Be Kind to Kidneys are registered Trademarks of Osprey Medical, Inc. in the United States and other countries.

LinkedIn IconYouTube IconTwitter icon

Contact     Resources     Privacy     Terms of Use

Contact     Resources     Privacy     Terms of Use